Ask AI
ProCE Banner Activity

Islatravir Effects on Lymphocyte Counts in HIV Treatment and Prevention

Capsule Summary
Conference Coverage
Slideset

Overall, in HIV prevention and treatment trials, islatravir was associated with dose-dependent decreases from baseline in mean total lymphocyte and CD4+ counts. In prevention studies, lymphocyte counts returned to levels comparable to control after islatravir discontinuation.

Released: February 27, 2023

Expiration: February 26, 2024

Share

Supporters

Supported by educational grants from

Gilead Sciences, Inc.

Janssen Therapeutics, Division of Janssen Products, LP

Merck & Co., Inc.

ViiV Healthcare